Kinnate Biopharma Inc.
Records under this name other than the patents Kinnate Biopharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Kinnate Biopharma Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,667,634 | Inhibitors of Raf Kinases now held by Pierre Fabre Médicament, SAS In force · High confidence | In force | High confidence | |
| US 11,098,031 | Inhibitors of Raf Kinases now held by Pierre Fabre Médicament, SAS In force · High confidence | In force | High confidence | |
| US 12,312,336 | Inhibitors of Raf Kinases now held by Pierre Fabre Médicament, SAS In force · High confidence | In force | High confidence | |
| US 12,569,496 | Treatment of Cancer with a Raf Inhibitor now held by Pierre Fabre Médicament, SAS In force · Low confidence | In force | Low confidence | |
| US 11,407,737 | Inhibitors of Raf Kinases now held by Pierre Fabre Médicament, SAS In force · High confidence | In force | High confidence | |
| US 11,377,431 | Inhibitors of Raf Kinases now held by Pierre Fabre Médicament, SAS In force · High confidence | In force | High confidence | |
| US 11,746,095 | Inhibitors of Raf Kinases now held by Pierre Fabre Médicament, SAS In force · High confidence | In force | High confidence | |
| US 11,918,587 | Treatment of Cancer with a Raf Inhibitor now held by Pierre Fabre Médicament, SAS In force · Medium confidence | In force | Medium confidence | |
| US 11,753,395 | Inhibitors of Met Kinase now held by Celyn Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 11,814,384 | Inhibitors of Raf Kinases now held by Pierre Fabre Médicament, SAS In force · High confidence | In force | High confidence |